康妇炎胶囊结合盆腔炎治疗仪治疗盆腔炎所致慢性盆腔痛临床分析(1)
[摘要] 目的 对康妇炎胶囊结合盆腔炎治疗仪治疗盆腔炎所致慢性盆腔痛进行临床分析和探讨。 方法 方便选取该院2016年12月—2017年6月收治的82例盆腔炎所致慢性盆腔痛患者为对象，按照入院先后分为试验组和对照组，其中每组41例，对照组使用康妇炎胶囊进行治疗，试验组使用康妇炎胶囊结合盆腔炎治疗仪进行治疗，对两组的疗效、治疗情况、不良反应和满意度评分进行比较。 结果 试验组总体有效39例(95.12%)高于对照组33例(80.49%)，差异有统计学意义(P<0.05)。试验组治疗情况(疼痛缓解时间和住院天数)优于对照组，差异有统计学意义(P<0.05)。试验组不良反应情况发生(腹痛、呕吐、头晕)优于对照组，差异有统计学意义(P<0.05)。试验组总体满意39例(95.12%)高于对照组33例(80.49%)，差异有统计学意义(P<0.05)。 结论 康妇炎胶囊结合盆腔炎治疗仪治疗盆腔炎所致慢性盆腔痛疗效顯著，不良反应较少，患者较满意。
[关键词] 康妇炎胶囊；盆腔炎治疗仪；慢性盆腔痛
[中图分类号] R271 [文献标识码] A [文章编号] 1674-0742(2017)11(b)-0115-03
[Abstract] Objective This paper tries to discuss and analyze the Kangfuyan capsule combined with pelvic inflammation therapeutic apparatus in the treatment of pelvic inflammatory disease caused by chronic pelvic pain. Methods 82 cases of pelvic inflammatory disease caused by chronic pelvic pain treated in this hospital from December 2016 to June 2017 were convenient selected as the research objects， in accordance with the admission， they were divided into the experimental group and the control group， with 41 cases in each group， the control group used Kangfuyan capsules for treatment， the experimental group used Kangfuyan capsule combined pelvic inflammatory disease treatment instrument. The treatment efficacy， situation， adverse reactions and satisfaction scores of two groups were compared. Results The total efficacy of the experimental group was 39cases(95.12%)， higher than 33cases(80.49%) in the control group， with significant difference (P<0.05). The treatment situation in the experimental group (time of pain relief and hospitalization) were better than the control group， the difference was statistically significant (P<0.05). The occurrence of adverse reactions of experimental group (abdominal pain， vomiting， dizziness) were fewer than the control group， the difference was significant (P<0.05). The overall satisfaction in the experimental group was 39cases(95.12%)， higher than that of control group group of 33cases(80.49%)， with significant difference (P<0.05). Conclusion Kangfuyan capsule combined with pelvic inflammation therapeutic apparatus has a significant curative effect in the treatment of pelvic inflammatory disease caused by chronic pelvic pain， with less adverse reaction and high satisfaction rate of the patients.
[Key words] Kangfuyan capsule； Pelvic inflammation therapeutic apparatus； Chronic pelvic pain
在临床上，慢性盆腔痛是所有妇科疾病中最为常见的疾病之一，大多出现急性盆腔炎后会对女性生殖道和周围的各个组织造成一定程度的损伤，大部分粘连、增生、出现瘢痕，而使得局部神经纤维被刺激或压迫进而出现的症状[1-2]。其临床主要有下腹部坠涨甚至疼痛、月经紊乱、白带异常、腰肢酸软等表现[3]。大多出现病症的原因是出现急性盆腔炎后对其治疗不完全、不深入，经过妇科手术后可能出现感染、月经期间卫生差或体质较弱容易导致邻近组织器官出现炎症等[4]。近年来，人们的生活和工作的重心逐渐加大，随之带来的压力不可避免，长此以往使得免疫功能下降从而出现炎症，同时由于节育环和人工流产的人数增多使得进行此部位手术的几率大大增加，从而加大了慢性盆腔痛的发生[5]。为此该文以该院2016年12月—2017年6月接收治疗的82例盆腔炎所致慢性盆腔痛患者为研究对象，探讨康妇炎胶囊结合盆腔炎治疗仪的应用疗效，现报道如下。, http://www.100md.com(郑苏娟 徐颖)
[关键词] 康妇炎胶囊；盆腔炎治疗仪；慢性盆腔痛
[中图分类号] R271 [文献标识码] A [文章编号] 1674-0742(2017)11(b)-0115-03
[Abstract] Objective This paper tries to discuss and analyze the Kangfuyan capsule combined with pelvic inflammation therapeutic apparatus in the treatment of pelvic inflammatory disease caused by chronic pelvic pain. Methods 82 cases of pelvic inflammatory disease caused by chronic pelvic pain treated in this hospital from December 2016 to June 2017 were convenient selected as the research objects， in accordance with the admission， they were divided into the experimental group and the control group， with 41 cases in each group， the control group used Kangfuyan capsules for treatment， the experimental group used Kangfuyan capsule combined pelvic inflammatory disease treatment instrument. The treatment efficacy， situation， adverse reactions and satisfaction scores of two groups were compared. Results The total efficacy of the experimental group was 39cases(95.12%)， higher than 33cases(80.49%) in the control group， with significant difference (P<0.05). The treatment situation in the experimental group (time of pain relief and hospitalization) were better than the control group， the difference was statistically significant (P<0.05). The occurrence of adverse reactions of experimental group (abdominal pain， vomiting， dizziness) were fewer than the control group， the difference was significant (P<0.05). The overall satisfaction in the experimental group was 39cases(95.12%)， higher than that of control group group of 33cases(80.49%)， with significant difference (P<0.05). Conclusion Kangfuyan capsule combined with pelvic inflammation therapeutic apparatus has a significant curative effect in the treatment of pelvic inflammatory disease caused by chronic pelvic pain， with less adverse reaction and high satisfaction rate of the patients.
[Key words] Kangfuyan capsule； Pelvic inflammation therapeutic apparatus； Chronic pelvic pain
在临床上，慢性盆腔痛是所有妇科疾病中最为常见的疾病之一，大多出现急性盆腔炎后会对女性生殖道和周围的各个组织造成一定程度的损伤，大部分粘连、增生、出现瘢痕，而使得局部神经纤维被刺激或压迫进而出现的症状[1-2]。其临床主要有下腹部坠涨甚至疼痛、月经紊乱、白带异常、腰肢酸软等表现[3]。大多出现病症的原因是出现急性盆腔炎后对其治疗不完全、不深入，经过妇科手术后可能出现感染、月经期间卫生差或体质较弱容易导致邻近组织器官出现炎症等[4]。近年来，人们的生活和工作的重心逐渐加大，随之带来的压力不可避免，长此以往使得免疫功能下降从而出现炎症，同时由于节育环和人工流产的人数增多使得进行此部位手术的几率大大增加，从而加大了慢性盆腔痛的发生[5]。为此该文以该院2016年12月—2017年6月接收治疗的82例盆腔炎所致慢性盆腔痛患者为研究对象，探讨康妇炎胶囊结合盆腔炎治疗仪的应用疗效，现报道如下。, http://www.100md.com(郑苏娟 徐颖)